Multi-epitope Based Peptide Vaccine Candidate Against Babesia Infection From Rhoptry-Associated Protein 1 (RAP-1) Antigen Using Immuno-Informatics: An In Silico Approach
2024

Potential Vaccine Against Babesia Infection Using Immuno-Informatics

publication 10 minutes Evidence: moderate

Author Information

Author(s): Malgwi Samson Anjikwi, Adeleke Victoria T, Adeleke Matthew Adekunle, Okpeku Moses

Primary Institution: University of KwaZulu-Natal, Durban, South Africa

Hypothesis

Can a multi-epitope vaccine candidate be developed against Babesia infection using immunoinformatics?

Conclusion

The study successfully designed a multi-epitope vaccine candidate that is predicted to be antigenic, soluble, and non-allergenic.

Supporting Evidence

  • A multi-epitope vaccine comprising 11 CD8+, 17 CD4+, and 3 B-cell epitopes was constructed.
  • The designed vaccine was computationally predicted to be antigenic and soluble.
  • The vaccine construct comprises 595 amino acids with a molecular weight of 64,152 kDa.

Takeaway

Researchers created a new vaccine to help protect cattle from a disease called babesiosis by using computer programs to design it.

Methodology

The study used an immunoinformatics approach to design a multi-epitope vaccine candidate based on the RAP-1 antigen.

Limitations

The study is purely computational, requiring further experimental validation.

Digital Object Identifier (DOI)

10.1177/11779322241287114

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication